Fundamental dimension Equity attribute | IHRTPeer $1.87▲+8.72% Cap $250.0MP/E -1.0x QuantScore52/100 | AENTLeader $4.65▲+3.33% Cap $237.1MP/E 18.4x QuantScore54/100 | AMCXPeer $9.18▼-1.61% Cap $297.8MP/E -19.5x QuantScore44/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
46/100 |
63/100 |
31/100 |
Valuation Multiples, PEG & DCF upside | 74/100 | 62/100 | 80/100 |
Health Piotroski, Altman Z, leverage & liquidity | 37/100 | 40/100 | 22/100 |
Growth Revenue / earnings growth & margins | 42/100 | 7/100 | 35/100 |
Sentiment Analyst ratings, targets & revisions | 58/100 | 100/100 | 50/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -1.0x | 18.4x | -19.5x |
Forward P/E (next FY) | -3.7x | 9.0x | 7.9x |
EV / EBITDA (TTM) | 9.1x | 8.4x | 1.4x |
Price / Sales | 0.1x | 0.2x | 0.1x |
Price / Free Cash Flow | 6.9x | -87.0x | 1.6x |
PEG ratio | -0.12 | -1.34 | 0.12 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 4 / 9 | 5 / 9 |
Altman Z-Score | -0.30 (Distress) | 4.09 (Safe) | 1.79 (Distress) |
Total debt / equity | -2.87 | 0.80 | 1.92 |
Quick ratio | 1.4x | 0.7x | 1.8x |
Interest coverage | 0.0x | 4.7x | 1.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +0.3% | +8.0% | -4.5% |
Net income growth YoY | +53.2% | -13.4% | +139.5% |
Gross margin (TTM) | 56.8% | 12.9% | 48.3% |
Operating margin (FY) | 5.0% | 3.1% | 11.1% |
FCF margin (FY) | 0.3% | -0.2% | 11.8% |
5. Trailing price performancePrice change over period |
1M return | -17.3% | -4.7% | -23.5% |
3M return | -47.2% | -21.3% | -6.2% |
6M return | -65.5% | -36.6% | +4.8% |
Year to date | -55.0% | -42.5% | -3.6% |
1Y return | -44.8% | -22.9% | +20.3% |
3Y return | -21.8% | +252.3% | -21.5% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $14.07 +652.3% upside | $0.019 -99.6% premium | $225.31 +2354.3% upside |
Wall Street consensus target | $4.25 +127.3% · range $3.50–$5.00 | $9.50 +104.3% · range $8.00–$11.00 | $13.50 +47.1% · range $10.00–$23.00 |
Consensus stance | 40% Buy30% Hold30% Sell | — | 24% Buy56% Hold20% Sell |